These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11044835)

  • 1. Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma.
    Kono T; Kobayashi H; Ishii M; Nishiguchi S; Taniguchi S
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):966-8. PubMed ID: 11044835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C antibody and cryoglobulins in patients with cirrhosis and hepatocellular carcinoma.
    Rinaldi G; Saccardo F; Petrozzino MR; Bossi E; Manna MR; Monti G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S161-3. PubMed ID: 8730499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.
    Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ
    Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypes of hepatitis C virus in chronic liver disease in Taiwan.
    Chen CH; Sheu JC; Wang JT; Huang GT; Yang PM; Lee HS; Lee CZ; Chen DS
    J Med Virol; 1994 Nov; 44(3):234-6. PubMed ID: 7852966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type C hepatitis and hepatocellular carcinoma].
    Kobayashi K
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1947-52. PubMed ID: 1329669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.
    Silini E; Bottelli R; Asti M; Bruno S; Candusso ME; Brambilla S; Bono F; Iamoni G; Tinelli C; Mondelli MU; Ideo G
    Gastroenterology; 1996 Jul; 111(1):199-205. PubMed ID: 8698200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis.
    Saxena R; Ye MQ; Emre S; Klion F; Nalesnik MA; Thung SN
    Liver Transpl Surg; 1999 Jan; 5(1):81-2. PubMed ID: 9873096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis.
    Toshikuni N; Torigoe R; Mitsunaga M; Omoto A; Nakashima K
    World J Gastroenterol; 2006 Mar; 12(10):1641-4. PubMed ID: 16570363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in a patient with liver cirrhosis associated with negative serum HCV tests but positive liver tissue HCV RNA.
    Esaki T; Suzuki N; Yokoyama K; Iwata K; Irie M; Anan A; Nakane H; Yoshikane M; Nishizawa S; Ueda S; Sohda T; Watanabe H; Sakisaka S
    Intern Med; 2004 Apr; 43(4):279-82. PubMed ID: 15168768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
    Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma.
    Kato Y; Hamasaki K; Aritomi T; Nakao K; Nakata K; Eguchi K
    Oncol Rep; 1999; 6(6):1273-6. PubMed ID: 10523695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
    Tarao K; Rino Y; Takemiya S; Tamai S; Ohkawa S; Sugimasa Y; Miyakawa K; Morinaga S; Yoshida M; Shibuya A; Kokubu S; Kakita A; Endo O
    Intervirology; 2000; 43(1):20-6. PubMed ID: 10773734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.